Glycoproteomic analysis of tissues from patients with colon cancer using lectin microarrays and nanoLC-MS/MSElectronic supplementary information (ESI) available. See DOI: 10.1039/c3mb00013c

• Main Authors: Li, Yangguang, Wen, Ti, Zhu, Minzhi, Li, Lixin, Wei, Jun, Wu, Xiaoli, Guo, Mingzhou, Liu, Shuangping, Zhao, Huiyuan, Xia, Siyuan, Huang, Weili, Wang, Puyue, Wu, Zhenzhou, Zhao, Liqing, Shui, Wenqing, Li, Zheng, Yin, Zhinan
• Format: Journal Article
• Language: English
• Published: 04.06.2013
• ISSN: 1742-206X; 1742-2051
• DOI: 10.1039/c3mb00013c

The current study evaluated the glycoproteomic profile of tissues from colon cancer patients. The lectin microarray was first performed to compare the glycoprotein profiles between colon cancer and matched normal tissues. Level of N -acetylglucosamine (GlcNAc) that Solanum tuberosum lectin (STL) bound was found to be elevated in colon cancer, which was verified through lectin histochemistry. The subsequent glycoproteomic analysis based on STL enrichment of glycoproteins followed by label-free quantitative nano liquid chromatography-mass spectrometry/mass spectrometry (nanoLC-MS/MS) analysis identified 72 proteins in high confidence. Among these proteins, 17 were exclusively detected in cancer tissues, and 14 were significantly upregulated in tumor tissues. Annexin A1 and HSP90 were chosen for further investigation by immunoprecipitation coupled with lectin blots, western blots and tissue microarrays. Both Annexin A1 and HSP90 were GlcNAcylated, and their protein expressions were elevated in colon cancer, compared to normal tissues. Moreover, specific changes of GlcNAc abundances in Annexin A1 and HSP90 suggested that tumor-specific glycan patterns could serve as candidate biomarkers of colon cancer for distinguishing cancer patients from healthy individuals. Both GlcNAcylation level and protein expression of Annexin A1 and HSP90b were elevated in colon cancer.